Jay Johnston - Luminex Independent Director

Director

Mr. Jay B. Johnston is an Independent Director of Luminex Corporationration, since February 2005. From 20012013, Mr. Johnston served as Chairman of QuesTek Innovations, LLC, a privatelyheld company that designs and markets high tech materials. From 19751999, he held numerous positions at Abbott Laboratories, a global, broadbased health care company, most recently as corporate vice president for diagnostic assays and systems. He held numerous other positions with Abbott, including president of Dainabot Co. Ltd. and vice president Asia Pacific. Mr. Johnston has experience in general management, product development, technology management, strategic marketing and business development. He holds an M.B.A. in General Management from the Amos Tuck School of Business Administration and a B.A. degree in Public Administration from Dartmouth College. Mr. Johnston brings to the Board of Directors significant directly relevant industry experience in managing businesses in the diagnostics and life sciences industries. Mr. Johnston has extensive experience in leading the strategic and operational aspects of large complex, international organizations. Mr. Johnston knowledge of effective compensation processes for management helps him to guide the Company compensation programs and policies in his role as Chair of the Compensation Committee. Mr. Johnston also offers particular experience and perspective to the Board of Directors in the areas of product development and marketing strategies through his role on the Strategy and Development Committee. since 2005.
Age 71
Tenure 19 years
Professional MarksMBA
Phone512 219-8020
Webwww.luminexcorp.com
Johnston has experience in general management, product development, technology management, strategic marketing and business development. He holds an M.B.A. in General Management from the Amos Tuck School of Business Administration and a B.A. degree in Public Administration from Dartmouth College.

Luminex Management Efficiency

The company has return on total asset (ROA) of 5.06 % which means that it generated a profit of $5.06 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 4.97 %, meaning that it created $4.97 on every $100 dollars invested by stockholders. Luminex's management efficiency ratios could be used to measure how well Luminex manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 274.91 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Luminex has a current ratio of 8.2, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Luminex until it has trouble settling it off, either with new capital or with free cash flow. So, Luminex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Luminex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Luminex to invest in growth at high rates of return. When we think about Luminex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Uri HarRadcom
80
John KasardaOld Dominion Freight
72
Robert SingerCoty Inc
68
Sabine ChalmersCoty Inc
53
Jeffrey WardSaia Inc
59
John CongdonOld Dominion Freight
61
Edward WehmerStepan Company
67
Leo SuggsOld Dominion Freight
78
Patrick HanleyOld Dominion Freight
73
Michael WrayOld Dominion Freight
57
Randall DearthStepan Company
57
Mariasun LarreguiCoty Inc
57
Olivier GoudetCoty Inc
56
John GainorSaia Inc
61
Jan ReedStepan Company
61
Erhard SchoewelCoty Inc
71
Matty KarpRadcom
68
Bradley GaboschOld Dominion Freight
66
William EvansSaia Inc
70
Jack StahlCoty Inc
61
Gregory LawtonStepan Company
70
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Luminex Corporation was founded in 1995 and is based in Austin, Texas. Luminex Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1325 people. Luminex (LMNX) is traded on NASDAQ Exchange in USA and employs 1,325 people.

Management Performance

Luminex Leadership Team

Elected by the shareholders, the Luminex's board of directors comprises two types of representatives: Luminex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Luminex. The board's role is to monitor Luminex's management team and ensure that shareholders' interests are well served. Luminex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Luminex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nachum Shamir, CEO and Pres
Jim Kever, Independent Director
Thomas Erickson, Independent Director
Nancy Fairchild, Senior Vice President-Human resources
Jay Johnston, Independent Director
Todd Bennett, Senior Vice President - Global Sales and Customer Operations
Tadd Lazarus, Senior Vice President
Walter Loewenbaum, Independent Chairman of the Board
George Loewenbaum, Independent Chairman of the Board
Edward Ogunro, Independent Director
Randall Myers, Senior Vice President - Global Manufacturing and Quality
Kevin McNamara, Independent Director
Robert Cresci, Independent Director
Kenneth Samet, Director
Fred Goad, Independent Director
Richard Rew, Senior Vice President General Counsel, Secretary
Russell Bradley, Chief Marketing and Sales Officer and Sr. VP - Corporate Devel.
Stephen Eck, Independent Director
Harriss Currie, CFO, Principal Accounting Officer, Sr. VP of Fin. and Treasurer
Jimmy Kever, Independent Director
Matthew Scalo, Senior Director, Investor Relations

Luminex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Luminex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Luminex Stock

If you are still planning to invest in Luminex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Luminex's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like